Nextleaf Solutions Ltd. (OTCQB: OILFF) (CSE:OILS) (FSE:L0MA) provided an update on its specialty molecules division, specifically the company's patented novel route of manufacturing D9-tetrahydrocannabinol acetate, colloquially referred to as THC-O.
Nextleaf has recently produced THC-O under the company's Health Canada research license in anticipation of commercialization. Nextleaf has validated its manufacturing process of THC-O through third-party analytical testing.
The company is of the understanding that THC-O is not subject to excise tax as it does not meet the definition of "Total THC" as defined under the Excise Act 2001, which is aligned with …
Full story available on Benzinga.com
More Nextleaf To Launch THC-O As An Excise Tax-Free Alternative To Delta-9-THC